$-0.01 EPS Expected for R1 RCM Inc. (RCM) on March, 8

R1 RCM Inc. (NASDAQ:RCM)’s earnings release is anticipated by WallStreet on March, 8, RTT reports. Analysts forecast 87.50 % diference or $-0.01 from the $-0.08 EPS from 2018. Wall Street predicts -94.12 % EPS growth as of March, 8. The stock increased 1.70% or $0.15 during the last trading session, reaching $8.95.R1 RCM Inc. is uptrending after having risen 122.52% since February 12, 2018. RCM has 817,823 volume or 1.74% up from normal. The stock outperformed the S&P 500 by 122.52%.

R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States.The firm is valued at $986.58 million. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.Last it reported negative earnings. The firm also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services.

For more R1 RCM Inc. (NASDAQ:RCM) news released briefly go to: Nasdaq.com, Seekingalpha.com, Globenewswire.com, Nasdaq.com or Globenewswire.com. The titles are as follows: “R1 RCM to Release Fourth Quarter 2018 Results on February 22 – Nasdaq” released on February 07, 2019, “Medical Transcription Billing Is An Acquisition Machine – Seeking Alpha” on February 06, 2019, “R1 RCM Reports Third Quarter 2018 Results Nasdaq:RCM – GlobeNewswire” with a publish date: November 07, 2018, “Currency Exchange International Announces Financial Results for the Year and Three-Month Period Ended October 31, 2018 – Nasdaq” and the last “RCM Technologies, Inc. Announces Third Quarter Results – GlobeNewswire” with publication date: November 08, 2018.

R1 RCM Inc. (NASDAQ:RCM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.